Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. senior Avg
|
New words:
adhansia, Adlon, affiliate, allotted, analyzing, Annex, back, began, bore, Boston, bundled, Ciber, Circuit, Commave, concession, condensed, constraint, contrary, covenant, deficiency, deliverable, developmental, DSC, entirety, EPC, exceeded, expedient, faith, feedback, flexibility, floor, forebearance, forecasted, ground, GSA, Guarantor, Guaranty, Gurnet, hand, hindsight, hour, hourly, hundred, incentivize, inconformity, incremental, ineffective, Ironshore, JORNAY, Judge, Kingdon, lender, levied, licensee, lookback, magnitude, Master, median, member, noteholder, pari, passu, perpetually, PM, precise, precision, purely, Qualification, remedial, remediate, remediation, ROFR, Romania, runway, SA, sixty, standalone, subordinated, subpoena, subtenant, troubled, twenty, unconstitutional, underway, underwent, untested, upfront, vendor
Removed:
AbbVie, AG, Allergan, Arab, bona, clarified, copying, Costa, Danny, deduction, deterrence, diminishing, directed, diversity, eliminating, Endo, expressly, fide, fractional, generating, guideline, hereto, intensify, Interbank, interstate, introduced, introduction, Jump, London, lortab, Mallinckrodt, mature, measure, norco, objective, Oman, PHAST, prevailing, randomized, recapitalization, recapitalizing, reducing, referring, refinance, reorganization, repaid, representing, republication, rescheduled, restructure, Rica, Shionogi, SHS, summary, Symphony, team, tender, therefrom, Thompson, tolerability, underwriter, undesignated, vicodin, xodol
Filing tables
Filing exhibits
Related press release
ZVRA similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements (No. 333-234235 and No. 333-213926) on Form S-3 and Registration Statements (No. 333-203703, No. 333-210369, No. 333-216858, No. 333-224062 and No. 333-230041) on Form S-8 of KemPharm, Inc. of our report dated February 28, 2020 relating to the financial statements of KemPharm, Inc., appearing in this Annual Report on Form 10-K of KemPharm, Inc. for the year ended December 31, 2019.
/s/ RSM US LLP
Orlando, Florida
February 28, 2020